$4.50-0.73 (-13.96%)
Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. in the Healthcare sector is trading at $4.50. The stock is currently near its 52-week low of $1.62, remaining 7.4% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarke...
US equity futures were flat ahead of Thursday's opening bell as traders digested earnings from Pepsi
Gibo Holdings Ltd. 239,477,124 0.049